CULLERTON. 405 ILCS 5/2-102 from Ch. 91 1/2, par. 2-102 405 ILCS 5/2-107.1 from Ch. 91 1/2, par. 2-107.1 405 ILCS 5/2-110 from Ch. 91 1/2, par. 2-110 405 ILCS 5/2-110.1 new 405 ILCS 5/2-110.2 new 405 ILCS 5/2-110.3 new 405 ILCS 5/2-110.4 new 405 ILCS 5/3-209 from Ch. 91 1/2, par. 3-209 405 ILCS 5/3-800 from Ch. 91 1/2, par. 3-800 405 ILCS 5/3-814 from Ch. 91 1/2, par. 3-814 405 ILCS 5/3-814.1 740 ILCS 110/2 from Ch. 91 1/2, par. 802 740 ILCS 110/4 from Ch. 91 1/2, par. 804 740 ILCS 110/11 from Ch. 91 1/2, par. 811 Amends the Mental Health and Developmental Disabilities Code and the Mental Health and Developmental Disabilities Confidentiality Act. Adds procedures that must be followed before psychotropic medication or electro-convulsive therapy is administered, including a court hearing. Provides for registration of electro-convulsive therapy equipment with the Department of Public Health. Requires reports from facilities and physicians administering electro-convulsive therapy or other convulsive or coma-producing therapy. Provides that court hearings shall be open to the press and public unless the respondent or some other party requests that they be closed. Provides for a court appointment of a temporary and limited surrogate decision maker to consent to mental health and other services for a seriously mentally ill person who lacks the capacity to make a reasoned decision about necessary services. Makes other changes. 97-02-07 S FIRST READING 97-02-07 S REFERRED TO SENATE RULES COMMITTEE RULES 97-02-19 S ASSIGNED TO COMMITTEE PUBLIC HEALTH 97-02-27 S SPONSOR REMOVED SYVERSON 97-03-04 S POSTPONED 97-03-11 S POSTPONED 97-03-11 S COMMITTEE PUBLIC HEALTH 97-03-15 S RE-REFERRED TO RULES COMM/RULE 3-9(A) RULES 99-01-12 S SESSION SINE DIE END OF INQUIRY Full Text Bill Summary